miRNA gene miRNA_log2FC miRNA_pvalue gene_log2FC gene_pvalue interactions correlation_beta correlation_pvalue PMID evidence outcome cancer hsa-miR-140-5p SLC2A1 -0.755971041589807 9.68060922934542e-14 1.49657327542371 9.41739413554663e-37 MirTarget;miRanda;miRNATAP -0.15862393902483 0.000117946307705998 NA NA NA hsa-miR-152-3p SLC2A1 -0.26603867075042 0.0063861560676033 1.49657327542371 9.41739413554663e-37 MirTarget -0.14627536152481 0.00078600763240081 NA NA NA hsa-miR-199a-5p SLC2A1 -0.314703593105081 0.00909304983051124 1.49657327542371 9.41739413554663e-37 miRNATAP -0.183099662662108 1.64845049689103e-07 NA NA NA hsa-miR-214-5p SLC2A1 0.0510982283488062 0.676107227554816 1.49657327542371 9.41739413554663e-37 miRNATAP -0.111991341582227 0.00126381799679941 NA NA NA hsa-miR-22-3p SLC2A1 -0.505819481364718 1.90494905330622e-13 1.49657327542371 9.41739413554663e-37 miRNATAP -0.231463352235633 0.000161043010797231 25304371 In this study we found that GLUT1 is a direct target of miR-22; The ectopic expression of miR-22 inhibited breast cancer cell proliferation and invasion by targeting GLUT1; A reverse correlation between the expression of miR-22 and GLUT1 was observed in breast cancer tissue samples breast cancer hsa-miR-320a SLC2A1 -0.287921276129346 0.00141693637596294 1.49657327542371 9.41739413554663e-37 miRNAWalker2_validate -0.130020480753586 0.00584576293837947 NA NA NA hsa-miR-378a-3p SLC2A1 -1.79882978380301 1.05005373951733e-38 1.49657327542371 9.41739413554663e-37 MirTarget -0.147905443669812 3.71126789123233e-07 NA NA NA hsa-miR-378c SLC2A1 -1.79697571999492 1.07363220292403e-41 1.49657327542371 9.41739413554663e-37 MirTarget;miRNATAP -0.171375103944919 1.37113289395319e-08 NA NA NA hsa-miR-491-5p SLC2A1 -1.04307210952796 1.14586501470398e-15 1.49657327542371 9.41739413554663e-37 miRanda -0.123275180753375 0.000128166259808848 NA NA NA